Related Experiment Video
Updated: May 23, 2026
09:25
The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse
Published on: May 31, 2016
Sarcoidosis-associated fatigue.
Marjolein Drent1, Elyse E Lower, Jolanda De Vries
1Dept of Interstitial Lung Diseases, Hospital Gelderse Vallei, Ede, The Netherlands. m.drent@maastrichtuniversity.nl
The European Respiratory Journal
|March 24, 2012
Summary
Sarcoidosis-associated fatigue significantly impacts quality of life, often persisting despite treatment. Emerging evidence suggests neurostimulants like methylphenidate may offer effective relief for this debilitating symptom.
Area of Science:
- Pulmonary Medicine
- Rheumatology
- Neurology
Background:
- Fatigue affects 50-70% of sarcoidosis patients, severely impairing quality of life.
- The exact causes of sarcoidosis-associated fatigue are unclear and likely multifactorial, potentially involving granulomas, cytokines, and treatment side effects.
- Comorbidities such as depression, anxiety, hypothyroidism, and sleep disturbances can exacerbate fatigue in sarcoidosis patients.
Purpose of the Study:
- To explore the complex etiology of sarcoidosis-associated fatigue.
- To review current diagnostic approaches for identifying reversible causes of fatigue.
- To discuss emerging therapeutic strategies for managing persistent sarcoidosis-associated fatigue.
Main Methods:
- Comprehensive literature review of sarcoidosis-associated fatigue.
- Analysis of potential etiological factors including disease activity, treatment complications, and comorbidities.
- Evaluation of recent studies on novel treatment options.
Main Results:
- Fatigue in sarcoidosis is often not correlated with clinical disease activity parameters.
- Neurostimulants, such as methylphenidate, have shown promise in treating sarcoidosis-associated fatigue.
- Reversible causes must be thoroughly evaluated and addressed.
Conclusions:
- Sarcoidosis-associated fatigue is a complex, disabling symptom requiring extensive evaluation.
- While underlying causes and comorbidities should be managed, novel treatments like neurostimulants may provide additional benefit.
- Further research into the causes and effective therapeutic options, including psychological interventions, is warranted.
Related Concept Videos
01:21Fatigue
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
01:24Muscle Recovery and Fatigue
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...